Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

Journal of Clinical Oncology, Vol 24, No 24 (August 20), 2006: pp. 4041
© 2006 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2006.07.1902

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wilson, L. D.
Right arrow Articles by Smith, B. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wilson, L. D.
Right arrow Articles by Smith, B. D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

CORRESPONDENCE

Primary Cutaneous B-Cell Lymphoma

Lynn D. Wilson, Benjamin D. Smith

Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT

To the Editor:

We read with great interest the article by Zinzani et al1 regarding primary cutaneous B-cell lymphoma and associated clinical outcomes. The authors conclude that diffuse large B-cell lymphoma, leg type, has a significantly worse prognosis compared with follicle center and marginal-zone B-cell lymphomas of the skin with respect to overall survival. This study is important as it confirms the findings of several smaller studies such as that by Grange et al2 which previously identified disseminated disease and leg involvement as adverse prognostic features. The authors reference this important study in their text as "the previous largest series" of 145 patients, but the reference provided includes a variety of patients with T-cell lymphomas.3 We believe the authors intended to reference the series by Grange et al2 published in the Journal of Clinical Oncology in 2001, which specifically focused on patients with primary cutaneous B-cell lymphoma.

In 2005, our group published an analysis of nearly 1,000 patients with primary cutaneous B-cell lymphoma based on data from the Surveillance, Epidemiology and End Results program registry.4 That series spanned 1973 to 2001 and demonstrated the prognostic relationships between Surveillance, Epidemiology and End Results histology (which included over 400 patients with diffuse large B-cell lymphoma), anatomic location, and relative survival as well as adjusted risk of death. These findings served as the basis for a primary cutaneous B-cell lymphoma prognostic index that incorporates the combination of histology and anatomic distribution with adjustment for age, sex, race, and treatment with radiotherapy.

We feel that the findings of Zinzani et al1 are complementary and supportive to the primary cutaneous B-cell lymphoma prognostic index and that the clinical results from these large data sets, in addition to the other supportive literature, should serve as the basis on which future clinical decisions and prospective study should be based.

Authors' Disclosures of Potential Conflicts of Interest

The authors indicated no potential conflicts of interest.

REFERENCES

1. Zinzani PL, Quaglino P, Pimpinelli N, et al: Prognostic factors in primary cutaneous B-cell lymphoma: The Italian Study Group for Cutaneous Lymphomas. J Clin Oncol 24:1376-1382, 2006[Abstract/Free Full Text]

2. Grange F, Bekkenk MW, Wechsler J, et al: Prognostic factors in primary cutaneous large B-cell lymphomas: A European multicenter study. J Clin Oncol 19:3602-3610, 2001[Abstract/Free Full Text]

3. Grange F, Hedelin G, Joly P, et al: Prognostic factors in primary cutaneous lymphomas other than mycosis fungoides and the Sezary Syndrome: The French Study Group on Cutaneous Lymphomas. Blood 93:3637-3642, 1999[Abstract/Free Full Text]

4. Smith BD, Smith GL, Cooper DL, et al: The cutaneous B-cell lymphoma prognostic index: A novel prognostic index derived from a population based registry. J Clin Oncol 23:3390-3395, 2005[Abstract/Free Full Text]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wilson, L. D.
Right arrow Articles by Smith, B. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wilson, L. D.
Right arrow Articles by Smith, B. D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2006 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online